Epstein-Barr virus (EBV)-associated primary central nervous system lymphoma: Is incidence of EBV expression associated with median survival time?

Brain Tumor Pathology

Volumn 28, Issue 2, 2011, Pages 145-149

  Utsuki, Satoshi ^a   Oka, Hidehiro ^a   Miyajima, Yoshiteru ^a   Kijima, Chihiro ^a   Yasui, Yoshie ^a   Fujii, Kiyotaka ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

B cell lymphoproliferative disorder; Epstein Barr virus; Immunosuppressive; In situ hybridization; Primary central nervous system lymphoma

Indexed keywords

METHOTREXATE; VIRUS RNA;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MEGADOSE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; INCIDENCE; MALE; NONHUMAN; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL TIME; TISSUE SECTION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMORBIDITY; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; INCIDENCE; LYMPHOMA, B-CELL; MALE; METHOTREXATE; MIDDLE AGED; RETROSPECTIVE STUDIES; RNA, VIRAL; TREATMENT OUTCOME;

EID: 80052736724     PISSN: 14337398     EISSN: 1861387X     Source Type: Journal    
DOI: 10.1007/s10014-011-0020-x     Document Type: Article

References (20)

1. Committee of Brain Tumor Registry of Japan (2003) Report of brain tumor registry of Japan (1984-2000) Part I General features of brain tumors. Neurol Med Chir (Tokyo) 49 Suppl:S1-S25
2. Oyama T, Ichimura K, Suzuki R et al (2003) Senile EBV + B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol 27:16-26 (Pubitemid 36014895)
3. Kleinschmidt-DeMasters BK, Damek DM, Lillehei KO et al (2008) Epstein Barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications. J Neuropa-thol Exp Neurol 67:1103-1111
4. Hsiao SC, Ichinohasama R, Lin S et al (2009) EBV-associated diffuse large B-cell lymphoma in a psoriatic treated with meth-otrexate. Pathol Res Pract 205:43-49
5. Sierra del Rio M, Rousseau A, Soussain C et al (2009) Primary CNS lymphoma in immunocompetent patients. Oncologist 14:526-539
6. Oyama T, Yamamoto K, Asano N et al (2007) Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res 13:5124-5132 (Pubitemid 47502080)
7. Gibson SE, His ED (2009) Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype. Hum Pathol 40:653-661
8. Kuze T, Nakamura N, Hashimoto Y et al (2000) The characteristic of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV+ and EBV-cases in Japanese population. Jpn J Cancer Res 91:1233-1240 (Pubitemid 32042357)
9. Park S, Lee J, Ko YH et al (2007) The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood 110:972-978 (Pubitemid 47267436)
10. Yoshino T, Nakamura S, Matsuno Y et al (2006) Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma. Cancer Sci 97:163-166 (Pubitemid 43379485)
11. Kitai R, Matsuda K, Adachi E et al (2010) Epstein-Barr virus-associated primary central nervous system lymphoma in the Japanese population. Neurol Med Chir (Tokyo) 50:114-118
12. Sugita Y, Terasaki M, Niino D et al (2010) Epstein-Barr virus-associated primary central nervous system lymphomas in immunocompetent elderly patients: analysis for latent membrane protein-1 oncogene deletion and EBNA-2 strain typing. J Neu-rooncol 100:271-279
13. Ouyang Q, Wagner WM et al (2003) An age-related increase in the number of CD8+ T-cells carrying receptors for an immu-nodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness. Mech Ageing Dev 124:477-485 (Pubitemid 36519208)
14. Fagnoni FF, Vescovini R, Passeri G et al (2000) Shortage of circulating naïve CD8? T cells provides new insights on immunodeficiency in aging. Blood 95:2860-2868 (Pubitemid 30235896)
15. Thorley-Lawson DA, Gross A (2004) Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350:1328-1337 (Pubitemid 38375368)
16. Morales D, Beltran B, De Mendoza FH et al (2010) Epstein-Barr virus as a prognostic factor in de novo nodal diffuse large B-cell lymphoma. Leuk Lymphoma 51:66-72
17. Clybouw C, McHichi B, Mouhamad S et al (2005) EBV infection of human B lymphocytes leads to down-regulation of Bim expression: relationship to resistance to apoptosis. J Immunol 175:2968-2973 (Pubitemid 41170514)
18. Snow AL, Lambert SL, Natkunam Y et al (2006) EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosis. J Immunol 177:3283-3293 (Pubitemid 44277848)
19. Roychowdhury S, Peng R, Baiocchi RA et al (2003) Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma. Cancer Res 63:965-971 (Pubitemid 36278426)
20. Soussain C, Muldoon LL, Varallyay C et al (2007) Efficacy and MRI of rituximab and methotrexate treatment in a nude rat model of CNS lymphoma. Clin Cancer Res 13:2504-2511